Stock daily read

What happened with GRDN today?

Why it moved
Explains possible causes using the day’s news and filings
Moving with the market?
Uses market moves and trading volume to assess what drove the change
What to watch next
The next thing that could change the call, and what to look for

No read yet

Uses news and trading volume to explain the day’s move and how it relates to the market.

Investment outlook

GRDN in three months: buy, wait or sell?

Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.

In the report
  • Buy / Wait / Sell rating
  • 3-month target price
  • Bear · Base · Bull
  • vs. the market

Company

Company overview

Guardian Pharmacy Services operates local pharmacies serving residents of U.S. long-term care facilities. Most revenue comes from residents of assisted living and behavioral health facilities; skilled nursing residents account for most of the rest. Its pharmacies fill physicians’ prescriptions, package medicines by resident and administration time, and deliver them to facilities. Medication tracking and caregiver training help facility staff manage residents’ medicines.

The facilities provide access to residents, but they are not always the payer. Most revenue comes through Medicare Part D prescription drug plans, under reimbursement agreements negotiated with those plans. Medicaid, commercial insurers and healthcare providers also pay Guardian. For residents whose skilled nursing stay is covered by Medicare Part A, the nursing facility pays Guardian under its contract rather than Guardian receiving payment directly from Medicare.

The business depends on residents choosing its pharmacies and on reimbursement terms. Preferred-provider agreements with assisted living and behavioral health facilities do not automatically secure residents’ business, and state freedom-of-choice rules can prevent facilities from requiring residents to use Guardian. Its pharmacies must maintain state licenses and meet government program requirements, including the service standards needed to participate in Medicare Part D’s long-term care pharmacy networks.

Read allShow less
Source: SEC filing

Red flags

Know what’s buried in GRDN’s filings before you buy

The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.

Sorted into
  • Happening now
  • Could go wrong
  • Built in

Moat

GRDN says it has a moat. Does it hold up?

Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.

Each edge rated
  • Strong
  • Moderate
  • Limited
  • Unproven

Related companies

  • Competition
  • Shared drivers
  • Supplier
  • Customer

Guardian’s growth depends on winning long-term care residents against competitors including privately held PharMerica, while Medicare Part D reimbursement drives much of its revenue.

  • CVS Health’s Omnicare business competes with Guardian for the business of providing pharmacy services to long-term care facilities and their residents.

  • Guardian depends on Cardinal Health as one of its primary suppliers of drugs dispensed to long-term care residents; Cardinal earns revenue by selling drugs to pharmacies and other healthcare businesses. Its branded and generic drug supply and purchasing terms are the parts of its business most relevant to Guardian.

  • Guardian relies on McKesson as one of its primary wholesale suppliers for drugs dispensed to long-term care residents. McKesson sells branded and generic drugs to pharmacies and other customers through its North American Pharmaceutical business, making that business more relevant to Guardian than its prescription technology services.

Agenda

in 8 daysWed, Oct 28

  1. 2:00 PMET

    Fed Interest Rate Decision

    Guardian Pharmacy Services’ Fed-linked borrowing costs can rise or fall with interest rates if it draws on its revolving credit line, which was undrawn at year-end 2025.

in 15 daysWed, Nov 4

  1. Time to be announced

    CVS HEALTH CORPORATION earningsCVS

    CVS Health’s report offers clues about its Omnicare long-term-care pharmacy business, which competes with Guardian Pharmacy Services for facility and resident customers.

in 20 daysMon, Nov 9

  1. Time to be announced
    Major

    Guardian Pharmacy Services, Inc. earningsThis company

    Guardian Pharmacy Services’ report will show whether serving more long-term-care residents and filling more prescriptions is also producing enough gross profit to cover drug costs and reimbursement pressure.